Manufacturing Facility

Oncogen Pharma takes great pride in its state-of-the-art manufacturing plant, designed to meet the specific requirements of oncology and immunomodulatory drug production.

Specialized Oncology Drug Manufacturing

Our facility is purpose-built for the manufacturing of oncology drugs, ensuring the highest standards of safety, quality, and efficacy. With a dedicated and specialized infrastructure, we can handle the complexities associated with oncology drug production, ensuring that each medication meets stringent regulatory requirements.

Specialized Oncology Drug Manufacturing
IMGL5315

Cutting-Edge Technology

We have invested in the latest manufacturing technologies and equipment to ensure efficient and precise production processes. Our facility is equipped with advanced machinery, automated systems, Multi-products versatile facility with the flexibility to handle varied batch sizes and robust quality control measures to guarantee the consistency and integrity of our products.

Production Capacity
  We have the capacity to produce.

  22 Million tablets/per year.

  22 Million Capsules/per year.

  3 Million vials (Liquid & Lyo) /year.
Process Equipment
  Designed & Built with negative pressure Isolator.

  All the material is transferred through Closed Bin System using Split Butterfly valves and lifting columns. There is no open processing.

  All equipment provided with WHIP (wet in place) & CIP (clean in place) functions.

  All equipments are equipped with Audit Trail features in compliance with Data integrity guidelines.
Process Rooms
  Each Manufacturing suit is provided with Dedicated AHUs.

  HEPA filters installed in supply and return ducts of each room.

  The exhaust is equipped with a BIBO system.

  The HVAC system is controlled with a BMS system.

  Air showers installed at the exit of each room.
Previous
Next

Cutting-Edge Technology

We have invested in the latest manufacturing technologies and equipment to ensure efficient and precise production processes. Our facility is equipped with advanced machinery, automated systems, Multi-products versatile facility with the flexibility to handle varied batch sizes and robust quality control measures to guarantee the consistency and integrity of our products.

Production Capacity
  We have the capacity to produce.

  22 Million tablets/per year.

  22 Million Capsules/per year.

  3 Million vials (Liquid & Lyo) /year.
Process Equipment
  Designed & Build with negative pressure Isolator.

  All the material is transferred through Closed Bin System using Split Butterfly valves and lifting columns. There is no open processing.

  All equipment's provided with WIP (wet in place) & CIP (clean in place) functions.

  All equipment’s are equipped with Audit Trail features in compliance with Data integrity guidelines.
Process Rooms
  Each Manufacturing suit is provided with Dedicated AHUs.

  HEPA filters installed in supply and return ducts of each room.

  The exhaust is equipped with a BIBO system.

  HVAC system is controlled with a BMS system.

  Air showers installed at the exit of each room.
Previous
Next
IMGL5315

High-Containment Environment

To maintain the integrity of our operations and protect the health and safety of our employees, we have implemented a high-containment environment within our manufacturing plant. All the process wastes are first neutralized & then pass through the effluent treatment plant. This ensures strict control over potential hazards and contaminants, allowing us to manufacture potent oncology drugs safely and securely.

High Containment Environment
Compliance with international standards

Compliance with International Standards

We are committed to adhering to the highest international manufacturing standards. Our plant is designed by an International Engineering firm and constructed in accordance with guidelines set by regulatory authorities such as the Drug Regulatory Authority of Pakistan (DRAP), the Pharmaceutical Inspection Co-operation Scheme (PIC/s), and the World Health Organization's Good Manufacturing Practice (WHO GMP) guidelines. We undergo regular inspections and audits to ensure ongoing compliance and maintain the highest level of quality assurance.

Compliance with International Standards

We are committed to adhering to the highest international manufacturing standards. Our plant is designed by an International Engineering firm and constructed in accordance with guidelines set by regulatory authorities such as the Drug Regulatory Authority of Pakistan (DRAP), the Pharmaceutical Inspection Co-operation Scheme (PIC/s), and the World Health Organization's Good Manufacturing Practice (WHO GMP) guidelines. We undergo regular inspections and audits to ensure ongoing compliance and maintain the highest level of quality assurance.

Compliance with international standards

Oncogen Pharma Commitment

At Oncogen Pharma, our commitment extends beyond the physical infrastructure of our manufacturing plant. We are dedicated to upholding the highest standards of manufacturing excellence and ensuring the well-being of patients who rely on our medications. Key aspects of our commitment include:

At Oncogen Pharma, we are driven by our vision to be a leading producer of oncology generics in developing markets. Through our cutting-edge manufacturing facilities, unwavering commitment to quality, and dedication to patient well-being, we are proud to contribute to the global fight against cancer and provide accessible and affordable treatments to those in need.

Quality Operations

Quality is at the core of our manufacturing processes. We have implemented a comprehensive quality management system that covers all aspects of our operations, from raw material sourcing to finished product distribution. Our quality assurance team follows stringent protocols and continuously monitors and improves our processes to deliver pure, safe, effective, and reliable oncology drug products to patients.

To build continuous trust and long-term pursuit of quality excellence, we at Oncogen Pharma:

Ensure product safety and efficacy at all stages of manufacturing and supply chain by strictly adhering to current Good Manufacturing Practices.
Confirm full compliance by meeting relevant regulatory requirements and internal standards.
Endeavour zero defect through right first time approach and continuous improvement.
Engage everyone’s commitment across all functions of the organization by fostering a quality culture and best-in-class customer service.
Previous
Next
Quality Operations
Patient Centric Approach

Patient-Centric Approach

Our commitment to manufacturing excellence is driven by our dedication to patient well-being. We understand the critical importance of providing high-quality and affordable oncology medications to cancer patients. By leveraging our manufacturing capabilities, we aim to improve access to life-saving treatments and reduce the burden of cancer care.

Patient-Centric Approach

Our commitment to manufacturing excellence is driven by our dedication to patient well-being. We understand the critical importance of providing high-quality and affordable oncology medications to cancer patients. By leveraging our manufacturing capabilities, we aim to improve access to life-saving treatments and reduce the burden of cancer care.

Patient Centric Approach

Environmental Responsibility

We recognize our responsibility towards the environment and are committed to minimizing our ecological footprint. Our manufacturing plant is designed to be environmentally friendly, incorporating sustainable practices and technologies. We strive to minimize waste generation, conserve energy, and reduce the overall impact on the environment.

Environmental Responsibility
Continuous Improvement-2

Continuous Improvement

We are committed to continuous improvement in all aspects of our manufacturing operations. We invest in research and development, process optimization, and employee training to enhance efficiency, productivity, and product quality. By staying at the forefront of technological advancements and industry best practices, we aim to continuously raise the bar for manufacturing excellence.

Continuous Improvement

We are committed to continuous improvement in all aspects of our manufacturing operations. We invest in research and development, process optimization, and employee training to enhance efficiency, productivity, and product quality. By staying at the forefront of technological advancements and industry best practices, we aim to continuously raise the bar for manufacturing excellence.

Continuous Improvement-2